Our company recently received a Phase 2 Small Business Technology Transfer (STTR) award  of $1.5 million over a two year period for the Point Digit II, one of our original prosthetic products. The award was granted to us by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health. The project is titled “The Point Digit: A ratcheting prosthetic finger technology using advanced rapid manufacturing technology.”

As the leading prosthetic finger product on today's market, the Point Digit II allows many people with partial hand amputation to execute heavy-duty manual labor and delicate tasks requiring high dexterity. We worked hard to create this technology with clinical experts from around the world and our long-term research partners from the Biomechatronics Development Laboratory led by Bioengineering Professor Richard Weir on the University of Colorado Denver Anschutz Medical Campus. 

This award provides the opportunity to conduct a comprehensive nationwide clinical trial of our Point Digit II technology with our clinical partners Arm Dynamics. Clinical trial data is decisive for all parties involved in patient care including patients, prosthetists, occupational therapists, hand therapists, payers, and prosthetic device manufacturers. We are confident that these data will consequently help many people with partial hand amputation regain what was lost.

Please reach out if you have interest in working with us on this or other research projects.  All of our product development relies on partners to improve our research and development practices.  We look forward to working with more partners going forward.